Author: Ding, Peiyang; Zhang, Teng; Li, Yafei; Teng, Man; Sun, Yaning; Liu, Xiao; Chai, Shujun; Zhou, Enmin; Jin, Qianyue; Zhang, Gaiping
Title: Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2 Document date: 2017_7_24
ID: upb97on4_62
Snippet: The mechanism that AuNPs improved the NA level of Cap-based PCV2 subunit vaccine can be attributed to two aspects: first, although Cap protein bound to AuNPs at a very low percentage (0.6%) of total immunized protein, this part of binding protein was efficiently taken up by APCs and played a key role in activating the immune response. Each AuNP was capable of displaying 6-fold the amount of Cap protein than PCV2, resulting in a higher degree of B.....
Document: The mechanism that AuNPs improved the NA level of Cap-based PCV2 subunit vaccine can be attributed to two aspects: first, although Cap protein bound to AuNPs at a very low percentage (0.6%) of total immunized protein, this part of binding protein was efficiently taken up by APCs and played a key role in activating the immune response. Each AuNP was capable of displaying 6-fold the amount of Cap protein than PCV2, resulting in a higher degree of BCR cross-linking. The second and more important point, AuNPs directionally presented multiple neutralizing epitopes; thus, B cells simultaneously recognized more neutralizing epitopes, resulting in rapid proliferation of B-cell clones, which specifically target the neutralizing epitopes. Meanwhile AuNPs shielded the immunodominant epitope Cap (169-180), effectively reducing the antibody against this epitope, which plays a negative role in the production of NA.
Search related documents:
Co phrase search for related documents- immune response activate and subunit vaccine: 1
- immune response and key role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and low percentage: 1, 2, 3, 4
- immune response and NA level: 1
- immune response and NA production: 1
- immune response and negative role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- immune response and neutralize epitope: 1
- immune response and neutralizing epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- immune response and rapid proliferation: 1
- immune response and subunit vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- important second point and key role: 1
- key role and low percentage: 1
- key role and negative role: 1, 2, 3, 4, 5, 6
- key role and neutralizing epitope: 1, 2, 3, 4
- key role and rapid proliferation: 1
- low percentage and subunit vaccine: 1, 2
- NA level and NA production: 1, 2
Co phrase search for related documents, hyperlinks ordered by date